Evidence map›Paper›PMID 31455428›Full record

ArticleRadiation oncology (London, England)2019

Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases.

Stefan Janssen, Preena Mehta, Tobias Bartscht, Sebastian M Schmid, Fabian B Fahlbusch, Dirk Rades

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Stefan JanssenDepartment of Radiation Oncology, University of Lübeck, Lübeck, Germany. st-janssen@gmx.ne.
Preena MehtaDepartment of Radiation Oncology, University of Lübeck, Lübeck, Germany.
Tobias BartschtDepartment of Haematology and Oncology, University of Lübeck, Lübeck, Germany.
Sebastian M SchmidDepartment of Endocrinology, University of Lübeck, Lübeck, Germany.
Fabian B FahlbuschDepartment of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany.
Dirk RadesDepartment of Radiation Oncology, University of Lübeck, Lübeck, Germany.
University of Lübeck · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo quantify the prevalence of brain metastases involving the hypothalamic-pituitary (HT-P) area.

introductionCognitive impairment and fatigue are common side effects of whole brain irradiation (WBI) comprising the quality of life (QoL) for survivors. While the former is related to radiation-induced hippocampal injury, the latter could be secondary to hormonal disbalance as a consequence of radiation of the HT-P area. Thus, sparing both regions from higher irradiation doses could reduce these sequelae.

methodsT1 contrast medium enhanced magnetic resonance imaging (MRI) scans of 865 patients with brain metastases (4,280 metastases) were reviewed. HT-P area was individually contoured with a margin of 5 mm in order to evaluate the prevalence of brain metastases in this region.

resultsInvolvement of the hypothalamic region was found in 26 patients (involvement rate of 3% for patients and 1% for metastases), involvement of the pituitary gland in 9 patients (1% for patients and < 1% for metastases). Binary logistical regression analysis revealed the presence of > 10 brain metastases as the only factor associated with hypothalamic involvement while no distinct factor was associated with an involvement of the pituitary gland.

conclusionThe low prevalence of metastases within the HT-P area in patients with brain metastases calls for further studies examining whether sparing of this region might improve patients QoL.

Indexed as

AdultAgedAged, 80 and overBrain NeoplasmsCancer SurvivorsCranial IrradiationFemaleGermanyHippocampusHumansMagnetic Resonance ImagingMaleMiddle AgedNeoplasmsOrgans at RiskOrgan Sparing TreatmentsBrain metastasesHormonal impairmentHypothalamus/pituitary gland sparingQoLWhole brain radiotherapy

Identifiers

PMID31455428
PMCPMC6712746
OpenAlexW2971302844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.